Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H7O4S.Na |
| Molecular Weight | 162.14 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC(C)(O)S([O-])(=O)=O
InChI
InChIKey=YNJORDSKPXMABC-UHFFFAOYSA-M
InChI=1S/C3H8O4S.Na/c1-3(2,4)8(5,6)7;/h4H,1-2H3,(H,5,6,7);/q;+1/p-1
| Molecular Formula | C3H7O4S |
| Molecular Weight | 139.15 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:02 GMT 2025
by
admin
on
Mon Mar 31 17:50:02 GMT 2025
|
| Record UNII |
47VY054OXY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00883431
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
47VY054OXY
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
100000134299
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
1364858
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB61310
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
208-761-2
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
26211
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
540-92-1
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
23673833
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
m1338
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
47VY054OXY
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
C77446
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY |